Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.
| Image |  |
|---|---|
| Description | scientific article published on 19 April 2017 |
| Author/s |
author: Amany Zekry Steven Bollipo Gregory J Dore Edmund Tse Miriam T Levy |
| Publication date | January 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |